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Abstract: Adipokines influence energy metabolism and have effects on male reproduction, including
spermatogenesis and/or Sertoli cell maturation; however, the relationship between these active
proteins and androgens in testicular cells is limited. Here, we studied the impact of short-term
exposure to flutamide (an anti-androgen that blocks androgen receptors) on the expression of chemerin,
apelin, vaspin and their receptors (CCRL2, CMKLR1, GPR1, APLNR, GRP78, respectively) in adult rat
testes. Moreover, the levels of expression of lipid metabolism-modulating proteins (PLIN1, perilipin1;
TSPO, translocator protein) and intercellular adherens junction proteins (nectin-2 and afadin) were
determined in testicular cells. Plasma levels of adipokines, testosterone and cholesterol were also
evaluated. Gene expression techniques used included the quantitative real-time polymerase chain
reaction (qRT-PCR), Western blot (WB) and immunohistochemistry (IHC). The androgen-mediated
effects observed post-flutamide treatment were found at the gonadal level as chemerin, apelin,
and vaspin gene expression alterations at mRNA and protein levels were detected, whereas the
cellular targets for these adipokines were recognised by localisation of respective receptors in
testicular cells. Plasma concentrations of all adipokines were unchanged, whereas plasma cholesterol
content and testosterone level increased after flutamide exposure. Differential distribution of
adipokine receptors indicates potential para- or autocrine action of the adipokines within the rat
testes. Additionally, changes in the expression of PLIN1 and TSPO, involved in the initial step of
testosterone synthesis in Leydig cells, suggest that testicular cells represent a target of flutamide
action. Increase in the gene expression of PLIN1 and TSPO and higher total plasma cholesterol
content indicates enhanced availability of cholesterol in Leydig cells as a result of androgen-mediated
effects of flutamide. Alterations in adherens junction protein expression in the testis confirm the
flutamide efficacy in disruption of androgen signalling and presumably lead to impaired para- and
autocrine communication, important for proper functioning of adipokines.
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1. Introduction
Adipose-derived hormones, including adiponectin, leptin, visfatin, resistin, chemerin, apelin,
vaspin and many others, are called adipokines. These bioactive proteins act via binding to specific
receptors that are frequently located on cells that do not produce adipokines, suggesting a regulatory
mechanism that functions through endo- and/or paracrine interactions [1]. Adipokines, besides
influencing glucose utilisation, insulin sensitivity and energy homeostasis, have effects on both
female and male reproduction [2–4]. The effects of leptin on reproduction and fertility have been
investigated [5,6] and its impact to inducing puberty has been reviewed [7]. It was demonstrated that
adiponectin, along with other adipokines (e.g., leptin, resistin), plays a role in the interaction between
metabolism and reproductive functions at the hypothalamic, pituitary and gonadal levels (for review,
see [8,9]) in humans, rodents, and agronomic species. It should be added that a gender-dependent
function of adipokines (e.g., vaspin) has been recognised in humans, as women have markedly increased
plasma concentration of vaspin relative to men [10]. Deregulation of adipokine levels may lead to
various effects, e.g., obesity, type 2 diabetes and, in consequence, hypogonadism and subfertility [11,12].
Obesity, as disruptor of the male fertility, has been shown to be associated with disturbed sperm motility
and decreased testosterone levels [13]. Interestingly, a recent meta-analysis indicated that resistin and
visfatin affect spermatogenesis [14]. In a very recent study it was demonstrated that long treatment of
human cultured Sertoli cells with chemerin, visfatin or resistin at high concentrations (which are often
observed in obese men) suppresses FSH receptor expression and up-regulates that of the cytochrome
P450 CYP26A1, which in turn induces a phenotype characteristic of the pre-pubertal state [15]. It was
suggested that these adipokines negatively affect Sertoli cell maturation, possibly contributing to testis
dysfunction and fertility perturbations associated with obesity. Although the presence of chemerin and
visfatin has been detected in the human testis, data concerning the pathogenic role of other adipokines
in male reproductive disorders remain to be investigated.
It is to the point here that the link between adipokines and sex hormones is much better understood
in females than in males; however, the two most studied adipokines, leptin and adiponectin, have
emerged recently as pivotal signals involved in male reproduction [16–18]. It was reported that in rat
testes leptin through its own receptor inhibits testosterone secretion and leads to the impairment of
steroidogenic function of Leydig cells [19,20]. Adiponectin and its receptors have been demonstrated
in the chicken testis and found to influence steroidogenesis and spermatogenesis [21]. A relationship
between testosterone and adiponectin has been reported in the rat, showing that a developmental
exposure to isoflavones increases serum adiponectin level and decreases serum testosterone level [22].
A role of adiponectin as a factor modulating testis functioning during aging in mice has recently been
investigated [23]. It has also been suggested that in rodent and chicken testes visfatin influences
testicular aging by causing decreases in serum testosterone concentrations [24,25]. Another adipokine,
resistin, has been shown to increase testosterone synthesis, and perhaps Leydig cell proliferation [26].
Similarly, Hameed and colleagues [27] have reported increased testosterone levels in rat Leydig
cells in vitro after administration of visfatin. Visfatin has been observed in human spermatozoa and
concentrations in seminal plasma were found to be higher than blood plasma [28]. Lastly, a link
between adiponectin and leptin and estrogen signalling interactions has been reported in Leydig
cell tumours [29]. Since data regarding apelin, chemerin and vaspin functioning at the testicular
level are limited, or even completely absent [4,30,31], understanding the relationship between these
adipokines and androgens is of special interest. Precise cellular localisation of apelin, chemerin and
vaspin receptors is important to show the adipokine cellular targets within the testis.
Androgens play a vital role in the regulation of reproduction in males. Their effects are mediated by
the androgen receptor (AR). In the testis, the AR is present in testicular Leydig, Sertoli, and peritubular
cells [32]. This ligand-induced nuclear receptor plays a central role in androgen signalling. To test
whether the disruption of androgen signalling may have an effect on the presence of adipokines within
the testes, we used a pure nonsteroidal anti-androgen, flutamide, which is classified as a nuclear AR
antagonist that inhibits androgen by blocking its binding to the AR [33,34]. It was demonstrated that
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flutamide inhibits androgen action by blocking AR transcriptional activity, rather than by affecting
AR nuclear localisation in target cells [35]. In human medicine, flutamide is commonly used to treat
benign hyperplasia and carcinoma of the prostate. In animal models, the long-term effects of this
anti-androgen on male reproduction are well characterised [36–38], although its short-term effects on
the male gonad are still elusive [39]. We previously showed that flutamide produced diverse effects
on different cellular targets within adult rat testes. Short-term flutamide treatment had no effect on
the morphology of the seminiferous epithelium; however, it caused an apparent enlargement of the
interstitial tissue in which Leydig cells are located [40]. In the light of these findings, we proposed
that the tubular compartment and the intertubular compartment are variously sensitive to androgens
and a different set of cellular factors may be stimulated (or inhibited) by flutamide in various cell
types. In this study we asked whether short-term androgen withdrawal may induce changes in the
expression of adipokines and their receptors in Leydig cells within adult rat testes. We aimed to
investigate the mRNA and protein expression patterns of (1) chemerin and its three receptors, G protein
coupled receptor 1 (GPR1), chemokine like receptor 1 (CMKLR1) and chemokine CC motif receptor-like
2 (CCRL2); (2) apelin and its specific receptor APLNR; and (3) vaspin and the glucose-regulated
protein 78 (GRP78) in the testes of control and flutamide-treated rats using qRT-PCR, Western blot
(WB), and immunohistochemistry (IHC). Plasma levels of chemerin, apelin and vaspin were also
measured. Additionally, expression of two proteins (potential markers of lipid metabolism variations
in Leydig cells) including perilipin1 (PLIN1) and the translocator protein (TSPO) were detected to
reveal functional alterations in Leydig cells [41,42]. PLIN1 coats lipid droplets and serves as a protector
of energy stores by blocking lipid hydrolysis, while TSPO is localised in the outer mitochondrial
membrane of Leydig cells and is involved in lipid homeostasis [41,42]. As cholesterol availability is
important for testosterone synthesis in Leydig cells [43], plasma cholesterol content was also measured.
It has been proposed that proteins that constitute intercellular junctions within seminiferous
tubules may provide an “early warning” for testicular toxicants [44]. In this context, we asked
whether flutamide alters the expression of adherens junction proteins, nectin-2 and afadin, which are
present in Leydig cells. If it is the case, effectiveness of androgen deprivation by flutamide will be
confirmed. We hypothesise that androgen signalling disrupted by flutamide may have an impact
on the expression of chemerin, apelin and vaspin, and that altered expression of junctional proteins
induced by this antiandrogen may lead to impaired para- and autocrine communication, important for
proper functioning of adipokines. It is also tempting to speculate that the adipokines acting through
their respective receptors may contribute to modulation of Leydig cell functioning. The above working
hypotheses sound reasonable because the synthesis and secretion of adipokines within the testis are
likely to be controlled by androgen-mediated local interactions and can be working in concert with
junctional proteins.
2. Results
As has been stated in the introduction, short-term flutamide exposure influences morpho-functional
aspects of spermatogenesis in the rat [40,45]. On the other hand, it has been shown that AR-mediated
androgen signalling plays an important role in male metabolism by affecting the energy balance [46].
Androgens are implicated in energy homeostasis, i.a., regulating cholesterol synthesis and lipid
metabolism in the liver [47]. Here, we focus our attention on the influence of androgen signalling
disrupted by flutamide on the expression of chemerin, apelin and vaspin, as well as on the expression of
lipid metabolism-modulating proteins (PLIN1 and TSPO) at the gonadal level. A possible contribution of
these adipokines in the modulation of Leydig cell functioning, especially cholesterol availability, is also
taken into consideration. Of note, to show the adipokine cellular targets within the testes, localisation
of the chemerin, apelin and vaspin receptors is analysed immunohistochemically. Dependent on the
receptor distribution, para- and/or autocrine action of the abovementioned adipokines is suggested.
Finally, to confirm the flutamide effectiveness in the disruption of androgen signalling within the
testis, adherens junction protein expression is determined, while serum concentration of testosterone
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is measured to confirm an impairment of the negative feedback at the level of the pituitary gland.
It is suggested that post-flutamide changes in junctional protein expression may disturb para- and
autocrine communication, crucial for adipokines’ functioning.
2.1. Expression of Adipokines and Their Receptor Genes in Rat Testes, Effect of Flutamide
2.1.1. Immunolocalisation of Adipokines and Their Receptors
Positive signals for adipokines and their receptors were present in the testes of all rats assessed as
shown using IHC (Figure 1). Immunoreactive signals for chemerin and its two receptors (CCRL2 and
CMKLR1) (Figure 1A–C) and apelin and its receptor APLNR (Figure 1E,F) were confined to Leydig cells,
whereas GPR1 signals of moderate intensity were observed in Leydig cells and seminiferous tubules
(Figure 1D). Vaspin and GRP78 signals were distributed throughout both testicular compartments
and were from moderate to strong intensity in Leydig cells, Sertoli cells and germ cells (Figure 1G,H),
indicating potential para- or autocrine action of the adipokines within the rat testes. Flutamide
treatment resulted in decreased chemerin, CMKLR1, GPR1 and APLNR signals (Figure 1A’–B’,D’,F’),
while increases in apelin (Figure 1E’) were observed in Leydig cells relative to the control cells
(Figure 1A,B, D–F). The CCRL2 signals were very weak in Leydig cells of flutamide-exposed testes
(Figure 1C’) and almost invisible in the respective control testes (Figure 1C). After flutamide exposure,
vaspin signals decreased, while the intensity of GRP78 remained strong within the seminiferous tubules
and was weak to moderate within the interstitium (Figure 1G’–H’). No signals were detected for
chemerin, apelin and vaspin or their receptors when primary antibodies were omitted and replaced by
normal horse or goat serum (Figure 1A–H, A’–H’, insertion in upper left corner of microphotographs).
Qualitative analyses of signals from adipokines and their receptors were confirmed using
quantitative image analysis. Statistically significant differences from control values are denoted as
* p < 0.05; ** p < 0.01; *** p < 0.001 (Figure 1I).
2.1.2. Expression Levels of Adipokine and Adipokine Receptor Proteins
Proteins were observed as single bands near 18 kDa (chemerin), 47 kDa (CCRL2), 43 kDa
(CMKLR1), 41 kDa (GPR1), 46 kDa (apelin), 42 kDa (APLNR), 47 kDa (vaspin), 72 kDa (GRP78) and
42 kDa (β-Actin) (Figure 2A–H and Supplementary Figure S1). Quantitative measurements of protein
band intensities indicated changes in the expression levels in testes homogenates of flutamide-treated
vs. control rats. Chemerin and CMKLR1 levels decreased (p < 0.05) (Figure 2A,C), and CCRL2 levels
increased relative to controls (p < 0.05) (Figure 2B). Further, no significant change in levels of GPR1
(Figure 2D) were detected compared to its respective controls (Figure 2A–D). Increased levels of apelin
(p < 0.01) and decreased levels of APLNR (p < 0.01), vaspin, and GRP78 (p < 0.05) vs. controls were
observed (Figure 2E–H).
2.1.3. mRNA Expression Levels of Adipokines and Their Receptors
Electrophoresis revealed PCR-amplified products associated with chemerin, apelin, vaspin
and their receptors (Figure 3A). Real-time PCR assessing mRNA expression levels revealed the
down-regulation of Chemerin (p < 0.05), while transcripts of two chemerin receptors (Ccrl2 and Cmklr1)
were up-regulated (p < 0.05, p < 0.01, respectively), and no significant changes in Gpr1 expression levels
were noted post-flutamide treatment relative to controls (Figure 3B). Apelin, Aplnr, Vaspin, and Grp78
mRNA expression levels were down-regulated (p < 0.05 and p < 0.01) following flutamide exposure
compared to levels of controls (Figure 3B).
Changes in immunoreactivity associated with protein levels of adipokines and their receptors and
results regarding mRNA expression levels suggest a direct impact of flutamide at the gonadal level.
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chemerin (A–A’), CCRL2 (B–B’), CMKLR1 (C–C’), GPR1 (D–D’), apelin (E–E’), APLNR (F–F’), vaspin 
(G–G’) and GRP78 (H–H’). Representative microphotographs of control (A–H) and flutamide-treated 
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Figure 1. Qualitative (A–H, A’–H’) and quan itative (I) analys ohistochemical stain g
of chemerin (A,A’), CCRL2 (B,B’), CMKLR1 (C,C’), GPR1 ( , ’), apelin (E, ’), APLNR (F,F’), vaspin
(G,G’) and GRP78 (H,H’). Representative icrophotographs of control (A–H) and flutamide-treated
testes (A’–H’). Additionally stained with Mayer’s haematoxylin. Bars = 10 µm. Positive staining for
chemerin, CCRL2, CMKLR1, apelin and APLNR are restricted to Leydig cells (arrows), whereas staining
of GPR1, vaspin and GRP78 is visible in Leydig cells (arrows) and seminiferous tubules (open arrows).
Note the decreased levels of chemerin (A’), GPR1 (D’), APLNR (F’) and vaspin (G’) and increased levels
of CCRL2 (B’) and apelin (E’) intensities after flutamide administration. The intensity of CMKLR1 and
GRP78 staining in flutamide (C’,H’) and control (C,H) Leydig cells are similar. No immunopositive
staining of chemerin, apelin and vaspin and their receptors was observed when the primary antibodies
are omitted (A–H,A’–H’, insertion in upper left corner of microphotographs). Histograms (I) depicting
staining intensities of chemerin, apelin, vaspin, and their receptors are expressed as relative optical
density of the brown staining product in Leydig cells. The results are presented as means ± SD.
Statistically significant differences are flagged with asterisks (* p < 0.05, ** p < 0.01, *** p < 0.001).
Control (n = 6) and flutamide-treated (n = 6) animals; C: control, F: flutamide.
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CMKLR1 (C), GPR1 (D), apelin (E), APLNR (F), vaspin (G) and GRP78 (H) proteins in control and
flutamide-treated testes. Normalisation was performed with β-Actin as a loading control. Protein
levels within control testes were given a value of 1. Data obtained from three separate analyses are
presented as means ± SD. Statistically significant differences are flagged with asterisks (* p < 0.05,
** p < 0.01) between control (n = 6) and flutamide-treated (n = 6) anim ls; C: control, F: flutamide.
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2.2. Plasma Concentrations of Adipokines, Effect of Flutamide
No statistically significant differences were noted in plasma levels of chemerin, apelin and vaspin
in control and flutamide-treated males. (Table 1). It seems likely that total adipokine concentrations
are not affected by the anti-androgen treatment.
Table 1. Serum concentrations of studied adipokines in control and flutamide-treated rats.
Control Flutamide
Chemerin 12.736 ± 0.650 ng/mL 13.346 ± 1.116 ng/mL
Apelin 176.386 ± 41.236 pg/mL 192.110 ± 67.429 pg/mL
Vaspin 452.349 ± 15.379 pg/mL 488.864 ± 36.916 pg/mL
Data are expressed as means ± SD.
2.3. Testosterone Blood Plasma Concentration, Effects of Flutamide
Plasma testosterone concentrations markedly (6-fold) increased in flutamide-treated samples
(21.080 ± 4.879 ng/mL) relative to control samples (3.520 ± 0.901 ng/mL; p < 0.01). This indicates the
presence of flutamide-induced effects within the hypothalamus–pituitary–gonadal axis.
2.4. Plasma Cholesterol Content, Effects of Flutamide
Plasma cholesterol content (0.741 mmol/mL ± 0.019) was elevated in flutamide-exposed rats when
compared to the controls (0.593 mmol/mL ± 0.031, p < 0.01), which may suggest that flutamide altered
lipid homeostasis.
2.5. Expression of PLIN1 and TSPO Genes in Rat Testes, Effect of Flutamide
Immunohistochemistry analyses revealed positive staining for PLIN1 and TSPO throughout the
interstitial area (Figure 4A). Following flutamide treatment, both PLIN1 and TSPO signals were confined
to Leydig cells and increased in intensity in comparison to the respective controls. Qualitative IHC was
confirmed by densitometric image analysis (Figure 4A’). Concomitantly, significant increase in PLIN1
and TSPO protein levels were observed in flutamide vs. control rats (p < 0.05), and corresponding
mRNAs were also up-regulated (p < 0.01; p < 0.05, respectively) according to WB and qRT-PCR
analyses, respectively (Figure 4B,C’ and Supplementary Figure S1). Proteins were observed as single
bands near 56 kDa (PLIN1), 54 kDa (TSPO) and 42 kDa (β-Actin) (Figure 4B), while electrophoresis
revealed PCR-amplified products corresponded to expected sizes of 128, 51 and 257 bp for Plin1, Tspo,
and β-actin, respectively (Figure 4C and Supplementary Figure S1). Alterations in Plin1 and Tspo gene
expression levels indicated that flutamide treatment may have an impact on cholesterol availability in
Leydig cells and suggest the impact of flutamide at the gonadal level.
2.6. Expression of Nectin2 and Afadin Genes in Rat Testes, Effect of Flutamide
Specific post-flutamide effects in testes, determined via IHC, WB and qRT-PCR (Figure 5) were
as follows: reduced staining intensities of nectin-2 and afadin in Leydig cells (Figure 5A), confirmed
by densitometric image analysis (Figure 5A’), significant decreases in levels of both proteins (p < 0.01;
p < 0.05) (Figure 5B and Supplementary Figure S1) and the down-regulation of nectin-2 and afadin
mRNAs in testes of flutamide-treated rats (p < 0.05) compared to those of controls (Figure 5C’).
Proteins were observed as single bands near 60 kDa (nectin-2), 205 kDa (afadin) and 42 kDa (β-Actin)
(Figure 5B), whereas electrophoresis revealed that PCR products matched with the expected sizes of
150, 218 and 257 bp for Nectin2, Afadin, and β-actin, respectively (Figure 5C and Supplementary Figure
S1). Alterations in Nectin2 and Afadin gene expression levels indicated that the short-term flutamide
treatment is sufficient to induce specific effects on cell-cell junction proteins within Leydig cells.
Int. J. Mol. Sci. 2020, 21, 4439 8 of 19
Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 7 of 19 
2.5. Expression of PLIN1 and TSPO Genes in Rat Testes, Effect of Flutamide 
Immunohistochemistry analyses revealed positive staining for PLIN1 and TSPO throughout the 
interstitial area (Figure 4A). Following flutamide treatment, both PLIN1 and TSPO signals were 
confined to Leydig cells and increased in intensity in comparison to the respective controls. 
Qualitative IHC was confirmed by densitometric image analysis (Figure 4A’). Concomitantly, 
significant increase in PLIN1 and TSPO protein levels were observed in flutamide vs. control rats (p 
< 0.05), and corresponding mRNAs were also up-regulated (p < 0.01; p < 0.05, respectively) according 
to WB and qRT-PCR analyses, respectively (Figure 4B,C’). Proteins were observed as single bands 
near 56 kDa (PLIN1), 54 kDa (TSPO) and 42 kDa (β-Actin) (Figure 4B), while electrophoresis revealed 
PCR-amplified products corresponded to expected sizes of 128, 51 and 257 bp for Plin1, Tspo, and β-
actin, respectively (Figure 4C). Alterations in Plin1 and Tspo gene expression levels indicated that 
flutamide treatment may have an impact on cholesterol availability in Leydig cells and suggest the 
impact of flutamide at the gonadal level. 
Figure 4. Immunohistochemical localisation of PLIN1 and TSPO (A) and densitometric image analysis 
(A’), protein (B) and mRNA (C, C’) expression levels in control and flutamide-treated testes. 
Additionally stained with Mayer’s haematoxylin. Bars = 20 μm. In (A), representative 
microphotographs showing the cellular localisation of PLIN1 and TSPO signals in Leydig cells 
(arrows). Note higher intensity staining for both proteins in Leydig cells following flutamide exposure 
as shown also in (A’) Representative Western blots (B) and the relative levels of PLIN1 and TSPO 
proteins were normalised using β-Actin, which served as an internal protein loading control. Protein 
levels within control testes were given a value of 1. Representative RT-PCR and qRT-PCR analyses of 
Plin1 and Tspo mRNA expression levels in control and flutamide-exposed testes are shown in C and 
C’, respectively. Relative quantification (RQ) is expressed as mean ± SD. Statistically significant 
differences are flagged with asterisks (* p < 0.05, ** p < 0.01, *** p < 0.001) between control (n = 6) and 
flutamide-treated animals (n = 6); C: control, F: flutamide. 
2.6. Expression of Nectin2 and Afadin Genes in Rat Testes, Effect of Flutamide 
Specific post-flutamide effects in testes, determined via IHC, WB and qRT-PCR (Figure 5) were 
as follows: reduced staining intensities of nectin-2 and afadin in Leydig cells (Figure 5A), confirmed 
by densitometric image analysis (Figure 5A’), significant decreases in levels of both proteins (p < 0.01; 
p < 0.05) (Figure 5B) and the down-regulation of nectin-2 and afadin mRNAs in testes of flutamide-
treated rats (p < 0.05) compared to those of controls (Figure 5C’). Proteins were observed as single 
bands near 60 kDa (nectin-2), 205 kDa (afadin) and 42 kDa (β-Actin) (Figure 5B), whereas 
electrophoresis revealed that PCR products matched with the expected sizes of 150, 218 and 257 bp 
for Nectin2, Afadin, and β-actin, respectively (Figure 5C). Alterations in Nectin2 and Afadin gene 
expression levels indicated that the short-term flutamide treatment is sufficient to induce specific 
effects on cell-cell junction proteins within Leydig cells. 
Figure 4. Immunohistochemical localisation of PLIN1 and TSPO (A) and densitometric image analysis
(A’), protein (B) and mRNA (C, C’) expression levels in control and flutamide-treated testes. Additionally
stained with Mayer’s haemat xylin. Bars = 20µm. In (A), represe tative microphotographs showing the
cellular loc lisation f PLIN1 and TSPO signals in Leydig cells (arrows). Note higher intensity staining
for both proteins in Leydig cells following flutamide exposure as shown also in (A’) Representative
Western blots (B) and the relative levels of PLIN1 and TSPO proteins were normalised using β-Actin,
which served as an internal protein loading control. Protein levels within control testes were given a
value of 1. Representative RT-PCR and qRT-PCR analyse of Plin1 and Tspo mRNA expression levels in
control and flutamide-exposed testes are shown in C and C’, respectively. Relative quantification (RQ)
is expressed as mean ± SD. Statistically significant differences are flagged with asterisks (* p < 0.05,
** p < 0.01, *** p < 0.001) between control (n = 6) and flutamide-treated animals (n = 6); C: control,
F: flutamide.Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 8 of 19 
 
 
Figure 5. Immunohistochemical localisation of nectin-2 and afadin (A) and densitometric image 
analysis (A’), along with protein (B), and mRNA (C, C’) expression levels in testes of control and 
flutamide-exposed rats. Additionally stained with Mayer’s haematoxylin. Frames indicate the 
location of the higher-magnification views. Bars = 20 μm. In (A), representative microphotographs 
showing the cellular localisation of nectin-2 and afadin signals in Leydig cells (arrows) and in the 
apical compartment of seminiferous tubule (open arrows) of control and flutamide-treated 
testes.Note lower intensity staining for both proteins in Leydig cells following flutamide exposure as 
shown also in (A’). For details, see the higher magnification insets. Representative Western blots are 
shown in (B), and the relative levels of nectin-2 and afadin proteins were normalised using the internal 
protein loading control, β-Actin. Protein levels within control testes were given a value of 1. 
Representative RT-PCR and qRT-PCR analyses of Nectin2 and Afadin mRNA expression levels in the 
testes of control and flutamide-exposed males are shown in (C and C’), respectively. Relative 
quantification (RQ) is expressed as mean ± SD. Statistically significant differences are flagged with 
asterisks (* p < 0.05, ** p < 0.01) between control (n = 6) and flutamide-treated (n = 6) animals; C: control, 
F: flutamide. 
3. Discussion 
Although putative roles for adiponectin and leptin as endocrine factors that influence male 
reproduction in health and disease (in humans and laboratory animals) have been highlighted 
recently [18,48,49], limited information regarding the functioning of other adipokines within the male 
gonad is available. In this study, we sought to characterise the effects of short-term flutamide 
treatment on the expression of chemerin, apelin and vaspin and their receptors in adult rat testes. 
First, we showed reduced staining intensities of chemerin and CMKLR1 in Leydig cells and decreased 
levels of both proteins and chemerin mRNA, but increased CMKLR1 mRNA expression in flutamide-
treated testes. On the other hand, although CCRL2 mRNA and protein levels were up-regulated after 
flutamide exposure, a role for CMKLR1, rather than CCRL2, in mediating chemerin functioning in 
Leydig cells is suggested since the immunoreactive signal for CCRL2 was very weak in these cells. 
Of note, CCRL2 receptor has earlier been shown as a non-signalling receptor for chemerin in the 
ovary [50]. It seems likely that up- or down-regulation of protein expression post-flutamide exposure 
indicates an altered functional activity of Leydig cells which involves altered autocrine interactions. 
To date, only Li and colleagues [51,52] have shown the existence of chemerin and its receptors in 
Leydig cells, which has suggested a role for chemerin as a peripherally acting molecule in the testes. 
The research also suggested a suppressive effect for chemerin on hCG-stimulated testosterone 
synthesis in cultured rat Leydig cells. A very recent study involving the use of CMKLR1 knockout 
mice (CMKLR1-/-) assessed plasma testosterone levels and revealed that expression of enzymes 
implicated in testosterone production was lower in knockout mice compared to wild-type animals 
[53]. This work highlighted the importance of chemerin, which functions through CMKLR1 in male 
steroidogenesis. Herein, we demonstrated that GPR1 mRNA and protein levels of the third chemerin 
receptor in flutamide-treated and control animals were slightly different. GPR1 immunoexpression 
was decreased in Leydig cells and remained unchanged in seminiferous tubules of flutamide-treated 
Figure 5. Immunohistochemical localisati f ectin-2 and fadin (A) and densitometric image
analysis (A’), along with protein (B), and R A (C,C’) expression levels in testes of control and
flutamide-exposed rats. Additionally stained with Mayer’s haematoxylin. Frames indicate the location
of the higher-magnification views. Bars = 20 µm. In (A), representative microphotographs showing
the cellular localisation of nectin-2 and afadin signals in Leydig cells (arrows) and in the apical
compartment of seminiferous tubule (open arrows) of control and flutamide-treated testes.Note lower
intensity staining for both proteins in Leydig cells following flutamide exposure as shown also in (A’).
For details, see the higher magnification insets. Representative Western blots are shown in (B), and
the relative levels of nectin-2 and afadin proteins were normalised using th intern l prot in loading
control, β-Ac in. Protein levels within co trol testes were given a value of 1. R presentative RT-PCR
and qRT-PCR a alyses of Nectin2 and Afadin mRNA expression levels in the testes of con rol and
flutamide-exposed males are shown in (C,C’), respectively. Relative quantification (RQ) is expressed as
mean ± SD. Statistically significant differences are flagged with asterisks (* p < 0.05, ** p < 0.01) between
control (n = 6) and flutamide-treated (n = 6) animals; C: control, F: flutamide.
Int. J. Mol. Sci. 2020, 21, 4439 9 of 19
3. Discussion
Although putative roles for adiponectin and leptin as endocrine factors that influence male
reproduction in health and disease (in humans and laboratory animals) have been highlighted
recently [18,48,49], limited information regarding the functioning of other adipokines within the
male gonad is available. In this study, we sought to characterise the effects of short-term flutamide
treatment on the expression of chemerin, apelin and vaspin and their receptors in adult rat testes. First,
we showed reduced staining intensities of chemerin and CMKLR1 in Leydig cells and decreased levels
of both proteins and chemerin mRNA, but increased CMKLR1 mRNA expression in flutamide-treated
testes. On the other hand, although CCRL2 mRNA and protein levels were up-regulated after
flutamide exposure, a role for CMKLR1, rather than CCRL2, in mediating chemerin functioning in
Leydig cells is suggested since the immunoreactive signal for CCRL2 was very weak in these cells.
Of note, CCRL2 receptor has earlier been shown as a non-signalling receptor for chemerin in the
ovary [50]. It seems likely that up- or down-regulation of protein expression post-flutamide exposure
indicates an altered functional activity of Leydig cells which involves altered autocrine interactions.
To date, only Li and colleagues [51,52] have shown the existence of chemerin and its receptors in
Leydig cells, which has suggested a role for chemerin as a peripherally acting molecule in the testes.
The research also suggested a suppressive effect for chemerin on hCG-stimulated testosterone synthesis
in cultured rat Leydig cells. A very recent study involving the use of CMKLR1 knockout mice
(CMKLR1-/-) assessed plasma testosterone levels and revealed that expression of enzymes implicated
in testosterone production was lower in knockout mice compared to wild-type animals [53]. This work
highlighted the importance of chemerin, which functions through CMKLR1 in male steroidogenesis.
Herein, we demonstrated that GPR1 mRNA and protein levels of the third chemerin receptor in
flutamide-treated and control animals were slightly different. GPR1 immunoexpression was decreased
in Leydig cells and remained unchanged in seminiferous tubules of flutamide-treated vs. control
rats. This may suggest a dependence of chemerin on AR signalling through GPR1, which is specific
to Leydig cells, rather than seminiferous tubules. The results indicated that Leydig cells are the
location where chemerin operates through its own receptors, which is consistent with previously
published reports [21,54,55] showing adiponectin and its receptors present in rat and chicken testicular
Leydig cells.
Further, we showed that apelin and APLNR were distributed throughout Leydig cells, but were
not present in other cell types, indicating its autocrine mode of action within the Leydig cells. Flutamide
led to apparent decreases in APLNR signal intensities in Leydig cells; however, the immunoreactivity
of apelin increased. Such findings may be a result of the reduced activity of apelin at the gonadal
level after ARs were blocked by flutamide in adult rats. A suppressive role of apelin on central
hormonal regulation has been described by Sandal et al. [31], who noted that a diminished number of
Leydig cells and reduced serum testosterone concentrations occurred after intracerebroventricular
apelin-13 infusion. Although treatment with flutamide significantly down-regulated mRNA and
protein expression levels of chemerin, no correlation between mRNA and protein levels of apelin or
CMKLR1 (as indicated above) in the testes of flutamide-treated rats was found. We speculate that
decreases in apelin mRNA levels and concomitant increases in protein levels may suggest that enhanced
translation of the protein occurs in testes of treated males. On the other hand, increases in CMKLR1
mRNA and decreases in its protein expression may reflect that increased degradation of the protein
occurred as a result of flutamide exposure. According to Greenbaum et al. [56], both measurements
of mRNA and protein levels are important for understanding cellular functioning, but protein levels
cannot be predicted solely from mRNA levels.
Our results provide new information indicating that interstitial tissue is the only place within the
rat testis in which chemerin and apelin may act through CCRL2, CMKLR1 and APLNR, respectively.
Conversely, the vaspin signals were localised to Leydig cells, whereas the vaspin receptor (GRP78) was
present in both testicular compartments. Wide allocation of GRP78 within the seminiferous epithelium
suggests a possible role for vaspin in the regulation of Sertoli and germ cell functioning, rather than
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its involvement in the modulation of Leydig cell functioning. It is likely that vaspin acts locally in
the seminiferous tubular compartment as a paracrine and/or autocrine factor, presumably influencing
spermatogenesis. On the other hand, the unchanged expression pattern of GRP78 in the seminiferous
tubules of flutamide-treated rats indicates that in contrast to its anti-androgenic effects on vaspin,
GRP78 expression was not affected by the anti-androgen. The reason disturbed androgen signalling
(after treatment with flutamide) differentially affects expression of vaspin and GRP78 in various cellular
targets remains unclear; however, results may suggest that the deregulation of paracrine action occurs
in both testicular compartments of the rat. It is to the point here that the plasma chemerin, apelin
and vaspin levels remained unchanged post-flutamide treatment, indicating no androgen-mediated
effects of flutamide on the circulating adipokines’ concentrations. However, higher serum chemerin,
apelin and vaspin levels have earlier been reported in women with polycystic ovary syndrome and
hyperandrogenemia [4,57].
In addition to flutamide-induced effects at the hypothalamus–pituitary level reported both
previously [58,59] and in the present study (6-fold increase in plasma testosterone concentration),
functional alterations at the gonadal level, specifically in Leydig cells, were demonstrated. In the
enlarged interstitial space of flutamide-treated testes, PLIN1 and TSPO signals were strong and the
expression of both mRNA and protein levels was significantly elevated. Of note, cholesterol is a
substrate for testosterone production and is received from several cellular sources including lipid
droplets, which are located in Leydig cells [60]. Accordingly, PLIN1 proteins are widely distributed
in lipid droplets and in the endoplasmic reticulum of adipocytes, suggesting that perilipin levels
are influenced by nutritional changes [61]. In a clinical report previously published, the relationship
between plasma cholesterol and apelin levels were reported in patients with hypercholesterolemia for
whom lower apelin levels were determined [62]. Similarly, a relationship between high quantities of
lipids in the diet of mothers and expression of adiponectin and leptin in testes of male rat offspring
was detected [63,64]. Based on increased plasma cholesterol content and increased PLIN1 and TSPO
signals after flutamide exposure, it is suggested that availability of cholesterol in Leydig cells is
enhanced. Recently, Milon et al. reported [65] lipid homeostasis and metabolism to be affected by
endogenous and/or exogenous estrogens. However, the idea that adipokines acting through their
own receptors may increase lipid metabolism in Leydig cells cannot be excluded. The question arises
whether adipokines may modulate Leydig cell functioning through a mechanism that has not yet been
defined. It is worth adding that our previous morphometric analysis [40] revealed a marked increase
of interstitial volume, accompanied by a decreased number of Leydig cells per 1 mm2 of the interstitial
space, indicating the occurrence of Leydig cell hypertrophy after flutamide exposure. Elucidation
of whether a compensatory mechanism within Leydig cells exists will require further study at the
ultrastructural level.
Interestingly, investigating the efficacy of flutamide, we found specific effects that occurred within
Leydig cells. Levels of nectin-2 and afadin were down-regulated, mainly in the interstitium and,
to a lesser extent, within seminiferous tubules. Decreased expression of junction proteins following
flutamide exposure mirrored a report by Fiorini et al. [44], which showed that a gap junction protein
(connexin43; Cx43) was a specific target for testicular toxicants. According to Takai and Nakanishi the
presence of the nectin-afadin signals in testes reflects their role in the stability of cell to cell contacts [66].
In mice with nectin-2 deficiency, malformations in spermiogenesis, impaired sperm morphogenesis and
male-specific infertility have been observed [67,68]. An involvement of the nectin-afadin complex in
other heterotypic junctions between different testicular cell types, i.e., Sertoli cell-spermatid junctions,
has recently been reported [69]. As shown in our study, nectin-2 and afadin immunosignals were also
observed in the apical part of seminiferous tubules; however, both protein stainings were lower in
intensity compared to those in the interstitial compartment of the testis. We assume that changes in the
expression levels of cell–cell junction proteins in Leydig cells may lead to the impairment of para- and
autocrine communication, important for adipokines’ functioning. This assumption is in accordance
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with previously published reports showing that the adipokines function as paracrine and/or autocrine
factors in the female reproductive tract (for review, see [4,12,70]).
Altogether, the results presented here indicate that androgen deprivation by flutamide influences
the functioning of chemerin, apelin and vaspin in testes of adult rats and alters the gene expression of
PLIN1 and TSPO, enhancing cholesterol availability in Leydig cells. Alterations in adherens junction
protein expression in the testis confirm the flutamide efficacy and presumably may result in impaired
para- and autocrine communication, influencing adipokines’ functioning. Figure 6 presents a schematic
illustration of the interactions of flutamide with the adipokines, their receptors, the genes involved in
lipid metabolism and the relationship with the adherens junction proteins. We realise that suggested
interactions are speculative and should be tested in a future study. However, the distribution of
immunoreactive chemerin, apelin, and vaspin and their own receptors showed here adds a new
information about the adipokine cellular targets within rat testis.
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Figure 6. Schematic representation of local effects of flutamide in the rat testis. Interactions of 
flutamide with the adipokines, their receptors, the genes involved in lipid metabolism and the 
proposed relationship with the adherens junction proteins are presented. Flutamide, by blocking the 
igure 6. c tic r r s t ti f l c l ffects of fluta ide in the rat testis. Interacti s of
fluta ide with the adipokines, their receptors, the genes involved in lipid metabolism and the proposed
relationship with the adherens junction proteins are presented. Flutamide, by blocking the androgen
receptor (AR) in testicular cells, induces alterations in chemerin, apelin and vaspin gene expression
levels, mainly in Leydig cells. Distribution of CMKLR1, CCRL2 and APLNR, restricted only to
Leydig cells, indicates autocrine action of chemerin and apelin, whereas the localisation of GPR1
and GRP78 within Leydig cells and seminiferous tubule indicates the possibility of para- and/or
autocrine action of chemerin and vaspin. Both chemerin and apelin, acting through their own receptors,
are implicated in modulation of metabolic activity of Leydig cells by increasing the gene expression
of lipid metabolism-modulating proteins, PLIN1 and TSPO. Alterations in adherens junction protein
expression presumably lead to disturbed local communication, important for proper functioning
of adipokines. Additionally, vaspin acting through GRP78 likely regulates Sertoli and germ cell
functioning. Hypothetical interactions are marked with “?”.
4. Materials and Methods
4.1. Animals and Tissue Preparation
Adult Wistar male rats from five different litters were distributed by random allocation into
experimental (n = 6) and control (n = 6) groups. Rats in the experimental group received a daily
subcutaneous injection of flutamide (2-methyl-N-[4-nitro-3-(trifluoromethyl)-phenyl]propamide; (cat.
no.: F9397, Sigma-Aldrich, St. Louis, MO, USA) suspended in corn oil for seven consecutive days
(each dose, 50 mg⁄ kg body weight). Control rats were injected with corn oil only. A dose of flutamide
was selected as high enough to produce changes in the expression of cell–cell junction protein levels
without generating testicular germ cell loss from the seminiferous tubules. Treatment protocol was
evaluated according to the literature and our previously published data [40,45,71]. The animals were
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housed in a fully controlled standard environment (temperature 22 ◦C, relative humidity 55% ± 5%,
light:dark cycle of 12:12 h), with access to water and food ad libitum (Agropol, Motycz, Poland).
The animals from both groups were sacrificed by cervical dislocation after anesthesia with 4–5% (v/v)
isoflurane at 90 days of age. Testes were dissected and blood samples were collected from the dorsal
aorta using a heparinised syringe. Plasma concentrations of adipokines, cholesterol and testosterone
were measured using commercially available ELISA kits. Fresh tissue fragments were snap-frozen and
stored at −80 ◦C for qRT-PCR and WB analyses, or fixed in 4% paraformaldehyde, and embedded in
paraplast for IHC [72].
The use of animals and all protocols of animal experiments were approved by the Local Ethics
Committee in Krakow (permission numbers: 116/2012 and 85/2019).
4.2. Immunohistochemistry
For immunohistochemistry 5 µm thick paraffin-embedded sections of testes were used.
For improved IHC staining antigen retrieval, non-specific protein blocking and endogenous peroxidase
blocking were carried out, as described previously [40]. Briefly, testes sections were submerged in
10 mM citrate buffer (pH 6.0) and/or in Tris-EDTA buffer (pH 9.0) and boiled in a microwave oven
(2–3 min, 750 W). Subsequently, the sections were incubated (overnight at 4 ◦C) with primary antibodies
against chemerin, CCRL2, CMKLR1, GPR1, apelin, APLNR, vaspin and GRP78, PLIN1 and TSPO as
well as nectin-2 and afadin proteins (for details see Table 2).
Table 2. Details of primary antibodies used for Western blot (WB) and immunohistochemistry (IHC).
Antibody Host Species Vendor Cat. Number Dilution
Anti-chemerin Rabbit Abcam ab103153 1:500 (WB)1:200 (IHC)
Anti-CCRL2 Rabbit Sigma-Aldrich SAB2100371 1:1000 (WB)1:200 (IHC)
Anti-CKMLR1 Rabbit Abcam ab64881 1:500 (WB)1:200 (IHC)
Anti-GPR1 Goat Santa Cruz Biotechnology sc-48178 1:200 (WB)1:200 (IHC)
Anti-apelin Mouse Santa Cruz Biotechnology sc-293441 1:1000 (WB)1:200 (IHC)
Anti-APLNR Mouse Santa Cruz Biotechnology sc-73713 1:500 (WB)1:200 (IHC)
Anti-vaspin Rabbit ThermoFisher Scientific PA5-30989 1:500 (WB)1:500 (IHC)
Anti-GRP78 Rabbit ThermoFisher Scientific PA5-19503 1:500 (WB)1:500 (IHC)
Anti-PLIN1 Goat Abcam ab61682 1:300 (WB)1:400 (IHC)
Anti-TSPO Rabbit Bioassay Technology Laboratory BT-AP06962 1:400 (WB)1:200 (IHC)
Anti-nectin-2 Rabbit Bioassay Technology Laboratory BT-AP04642 1:1000 (WB)1:100 (IHC)
Anti-afadin Rabbit Bioassay Technology Laboratory BT-AP06988 1:500 (WB)1:100 (IHC)
Anti-β-actin Mouse Sigma-Aldrich A2228 1:500 (WB)
Thereafter, sections were incubated for 30 min with biotinylated secondary antibody goat
anti-rabbit, horse anti-mouse or horse anti-goat (1:400; cat. no.: BA-1000, cat. no.: BA-2000 or cat. no.:
BA-9500, respectively; Vector, Burlingame, CA, USA). All antibodies were diluted in Tris-buffered
saline (TBS; 0.05 M Tris-HCl, 0.15 M NaCl, pH 7.6). During procedure, after each incubation, sections
were washed in TBS 3 times for 5 min each. The staining signal was amplified by incubation for
30 min with avidin-biotinylated horseradish peroxidase complex (ABC/HRP; 1:100; Vectastain Elite
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ABC Reagent, Vector Lab.) and by 0.05% 3.3′-diaminobenzidine tetrachloride (DAB; cat. no.: D5637,
Sigma-Aldrich) dissolved in TBS containing 0.01% (v/v) H2O2 and 0.07% (wt/v) imidazole. Lastly,
all sections were rinsed and additionally stained with Mayer’s haematoxylin (cat. no.: 124687402,
CHEMPUR, Piekary Slaskie, Poland), dehydrated and coverslipped with DPX mounting medium
(Sigma-Aldrich). All procedures were performed identically at the same time to ensure uniformity and
specificity of the staining [38]. As a negative control, primary antibody was omitted and replaced by
an irrelevant IgG. Sections were examined with a Leica DMR microscope (Leica Microsystems GmBH,
Wetzlar, Wetzlar, Germany).
For quantitative analysis, digital color images of testes sections were acquired using a
charge-coupled device (CCD) video camera mounted on an optical microscope (Microphot, Nikon,
Japan). Images were processed using ImageJ software (National Institutes of Health, Bethesda,
MD, USA). The intensities of IHC staining were expressed as relative optical density (ROD) of
diaminobenzidine brown reaction products, defined previously by Smolen [73]. Image analysis were
performed on 24 randomly selected tissue sections of control (n = 6) and flutamide-treated (n = 6)
testes. Measurement values were expressed as mean ± SD.
4.3. Western Blot Analysis
Tissue samples of the testes were homogenised in cold-ice radio-immuno-precipitation assay
buffer (RIPA, pH 8.0; Thermo Scientific; Inc., Rocheford, Il, USA) containing protease inhibitor cocktail
(Sigma-Aldrich), sonicated and centrifuged as described previously [74]. Protein concentrations were
determined by performing the Lowry assay (Bio-Rad Labs, GmbH, München, Germany). Proteins
were separated by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and
immobilised in polyvinylidene fluoride membranes, as described before [67]. To prevent non-specific
binding of antibodies membranes were raised with non-fat dry milk (5%, wt/v) containing 0.1% Tween
20 (v/v). After blocking, the membrane was incubated with the primary antibodies (Table 2) at 4 ◦C
overnight. Next, after washing membranes with TBST buffer (0.05 M Tris-HCl, 0.15 M NaCl, pH 7.6
containing 0.1% Tween 20) secondary antibody was added (1:3000; Vector Laboratories, Burlingame,
CA, USA), and incubated for 1 h at room temperature with gentle rocking. Chemiluminescent
signals on Western blot were detected and captured with a ChemiDocTM XRS + System (Bio-Rad
Laboratories). All blots were stripped at 50 ◦C for 30 min (stripping solution, 62.5 mM Tris- HCL,
100 mM 2-mercaptoethanol, 2% SDS (wt/v) (pH 6.7)), and subsequently re-probed with an additional
antibody against β-actin (dilution, 1:3000; Sigma-Aldrich), which was used as a loading control and for
normalisation. Protein molecular weight marker (ColorBurst Electrophoresis Marker, Sigma-Aldrich)
was run, to calculate molecular weight of target proteins. The bands were analysed and quantified
with Image LabTM 2.0 (Bio-Rad Laboratories).
4.4. RNA Extraction, Reverse Transcription
The frozen testes were used for RNA isolation with TRIzol reagent (Life Technologies, Gaithersburg,
MD, USA). To remove DNA contamination from RNA samples TURBO DNase free Kit (Ambion,
Austin, TX, USA) was applied, following the manufacturer’s protocols. For assessing RNA quality
the A260:A280 ratio was measured using a NanoDrop ND2000 Spectrophotometer (Thermo Scientific,
Wilmington, DE, USA) and by electrophoresis. The purified total RNA (1 µg) was reverse transcribed
into cDNA using cDNA reverse transcription kit (Applied Biosystems, Carlsbad, CA, USA) according
to the manufacturer’s instructions. The total mixture (20 µL) contained cDNA, random primers,
dNTPmix, RNAse inhibitor and reverse transcriptase (RT). For each RNA sample the same reactions in
the absence of RT were performed.
4.5. Real-Time Quantitative RT-PCR
Real-time RT-PCR analyses were carried out using a StepOne Real-Time PCR system (Applied
Biosystems) with the cDNA templates and optimised standard conditions as described previously [75].
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The primers for the genes, provided by Institute of Biochemistry and Biophysics, Polish Academy of
Sciences (Warsaw, Poland), are listed in Table 3.
Table 3. Sequences of forward and reverse primers.
Genes Primers (5’–3´) Product Size (bp) Annealing Temp. (◦C)
Chemerin 5
′-TGTGCAGTGGGCCTTCCA-3′
5′-CAAAGGTGCCAGCTGAGAAGA-3′ 71 55
Ccrl2 5
′-TGTGTTTCCTGCTTCCCCTG-3′
5′-CGAGGAGTGGAGTCCGACAA-3′ 101 60
Ckmlr1 5
′-CAAGCAAACAGCCACTACCA-3′
5′-TAGATGCCGGAGTCGTTGTAA-3′ 234 52
Gpr1 5
′-GGAGCTCAGCATTCATCACA-3′
5′-GACAGGCTCTTGGTTTCAGC-3′ 243 53
Apelin 5
′-AGACCCCGGAGGCTAAGGAGTT-3′
5′-TCCGTCATAGTGTCCTCCATCA-3′ 300 62
Aplnr 5
′-GGACTCCGAATTCCCTTCTC-3′
5′-CTTGTGCAAGGTCAACCTCA-3′ 140 53
Vaspin 5
′-CTGAAACTGGCTAAGAACT-3′
5′-CACCTGCCTTGAAAGTAAAT-3′ 191 47
Grp78 5
′-CTGGGTACATTTGATCTGACTGG-3′
5′-GCATCCTGGTGGCTTTCCAGCCATTC-3′ 398 64
Plin1 5
′-TGCGCAAGAAGAGCTGAGTA-3′
5′-AGAGGCCAACCTGAAGGAGT-3′ 128 53
Tspo 5
′-GCTGGACACTCGCTCCCA-3′
5′-CATACCCCATGGCCGAATAC-3′ 51 54
Nectin2 5
′-CGGAACTGTCACTGTCACCA-3′
5′-GACACTTCAGGAGGGTAGCG-3′ 150 57
Afadin 5
′-CCGACATCATCCACCACTGG-3′
5′-CAGCATTCGCATATCAGGTCG-3′ 218 60
β-actin 5
′-AAGTACCCCATTGAACACGG-3′
5′-ATCACAATGCCAGTGGTACG-3′ 257 52
Gapdh 5
′-ACCACAGTCCATGCCATCAC-3′
5′-TCCACCACCCTGTTGCTGTA-3′ 452 55
Rpl13a 5
′-CATTCGAACGTCTGCCCTAT-3′
5′-GTTTCTCAGGCTCCCTCTCC-3′ 128 56
Amplification efficiency (ranging from 97% to 104%) was calculated as described by Svec et al. [76].
The amplification was performed with 10 ng cDNA, 0.5 mM of each primers and SYBR Green master
mix (Applied Biosystems). The amplification specificity of expected PCR products was confirmed by
melting curve analysis and agarose gel electrophoresis. All experiments were performed in triplicate
and repeated in independent experiments three times. The 2-∆∆Ct method was used to determine the
relative quantification (RQ) of the target genes: Chemerin, Ccrl2, Cmklr1, Gpr1, Apelin, Aplnr, Vaspin,
Grp78, Nectin2, Afadin, Plin1 and Tspo. The mRNA expressions were normalised to the mean expression
of reference genes β-actin, Gapdh and Rpl13a (RQ = 1) [77]. In Figures 3–5, as an internal control,
representative β-actin transcript level was shown. In all real-time RT-PCR reactions, negative controls
were carried out.
4.6. Enzyme-Linked Immunosorbent Assay (ELISA) Analysis
Commercially available rat enzyme-linked immunosorbent assays (ELISA) were used to quantify
total chemerin (cat.no.: MBS774364, MyBioSource Inc., San Diego, CA, USA), apelin (cat. no.:
MBS725297, MyBioSource Inc.), vaspin (cat. no.: MBS2501454, MyBioSource Inc.), cholesterol (cat.
no.: E0784Ra, Bioassay Technology Laboratory) and testosterone (cat. no.: EIA-1559, DRG, Inc.
Int. Springfield, NJ, USA) concentrations in plasma. For all measurements, samples of control
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and flutamide-treated rats were used according to manufacturer’s protocols. Samples were run in
triplicate within the same experiment and measured by using a microplate reader (Labtech LT-4500,
Pocklington, UK).
4.7. Statistical Data Analysis
The raw data were processed using Statistica 10 software (StatSoft Inc., Tulsa, OK, USA). Normality
of data distribution was tested using the Shapiro–Wilk W-test. The non-parametric Mann–Whitney
U-test was conducted to determine statistical differences in protein and mRNA expression levels.
Data were presented as mean ± SD and considered statistically significant at * p < 0.05, ** p < 0.01,
*** p < 0.001.
5. Conclusions
The presence of chemerin, apelin and vaspin and their own receptors demonstrated here provides
new information about the adipokine cellular targets within rat testes. Furthermore, our results
indicate that androgen signalling disrupted by flutamide influences the functioning of abovementioned
adipokines and alters the gene expression of PLIN1 and TSPO, enhancing cholesterol availability in
Leydig cells. Alterations in Nectin2 and Afadin gene expression levels confirm the flutamide efficacy to
induce specific effects within Leydig cells and presumably may lead to impaired para- and autocrine
communication, crucial for proper functioning of adipokines.
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